R&D Scientist - Medicinal Chemistry
ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH
At ABX, I lead and contribute to medicinal chemistry projects within the R&D department, specializing in the design and synthesis of radioligand precursors for cancer imaging and therapy.
Key contribution:
• Development of radioligands for prostate and other epithelial cancers – design and synthesis of SARdriven analogue libraries optimizing binding affinity and biodistribution, minimizing off-target effects
• Design of dual-modality imaging probes combining radiolabelling moieties and fluorophores to enable both SPECT/PET and intraoperative fluorescence guidance through modular linker design
• Process optimization for compounds production – evaluation of different catalyst systems and reaction conditions and routes, significantly improving overall yields
• Custom synthesis of complex organic molecules for external clients and research institutes with high quality and purity standards for pre-clinical compounds.
















